Skip to main content

Finasteride Side Effects: What the Trial Numbers Show

Finasteride Side Effects

Almost everything people argue about with this drug traces back to one narrow action: it blocks the enzyme that turns testosterone into DHT, and DHT does work far beyond your hairline. The controlled trial numbers are small and the real-world accounts are not, and that gap is the honest story here rather than a settled question you can look up.

Serum DHT drop at 1 mg: ~70% Scalp DHT drop: ~60% Erectile dysfunction in trials: 1.3% vs 0.7% placebo Stopped over sexual symptoms: 1.2% vs 0.9% PSA reading suppressed: about half
Key Takeaway

At the 1 mg hair loss dose, finasteride lowers circulating DHT by roughly 70 percent, and the sexual side effects reported in its one-year approval trials ran between 1.2 and 1.8 percent against 0.7 to 1.3 percent on placebo.

How does finasteride work, and why does blocking DHT cause side effects?

The mechanism is narrow, and that's exactly why the side effect list looks the way it does. You're not lowering a hormone in your scalp; you're lowering it everywhere the enzyme happens to live, which includes your prostate, your genital skin, your liver and, through a second pathway, your brain chemistry.

  • Type II 5-alpha reductase: Blocked in scalp, prostate, genital skin, epididymis and liver alike.
  • DHT suppression: Roughly 70 percent in serum, roughly 60 percent in scalp tissue.
  • Neurosteroid pathway: The same enzyme makes allopregnanolone, which acts on brain GABA-A receptors.
  • Testosterone shift: Rises about 10 to 15 percent as the conversion route closes.
Expert Note

A 1 mg daily dose cuts serum DHT by about 70 percent and scalp DHT by about 60 percent, and because the same enzyme works in the prostate, genital skin, liver and brain, the side effects come from androgen and neurosteroid withdrawal in tissues that had nothing to do with your hair.

What sexual side effects does finasteride cause and how often do they occur?

Three complaints cover nearly all of it: lower libido, erectile difficulty, and reduced ejaculate volume. What most people never see is the placebo column sitting right next to the drug column, and once you put them side by side the attributable risk in year one turns out to be low but real.

Reported symptom 1 mg finasteride Placebo
Erectile dysfunction ~1.3% ~0.7%
Decreased libido ~1.8% ~1.3%
Ejaculation disorder ~1.2% ~0.7%
Stopped treatment for sexual reasons ~1.2% ~0.9%
Safety Note

In the one-year trials of the 1 mg dose, erectile dysfunction was reported by about 1.3 percent of men against 0.7 percent on placebo, an attributable risk on the order of one additional affected man per one hundred to two hundred treated.

What mood, cognitive, and psychological effects have been reported with finasteride?

These weren't in the original safety picture. They were added years later after reports piled up, and that history tells you how the signal was found: not by a trial designed to look for it, but by men describing something nobody had thought to measure.

  • Label changes: Depressed mood, depression and suicidal ideation added after post-marketing review.
  • Regulator position: Men on the 1 mg dose are told to stop and contact a clinician if those symptoms appear.
  • Split evidence: A large register cohort found no link to completed suicide but a raised rate of diagnosed depression.
  • Baseline confound: Hair loss itself lowers mood, so treated men were never a psychologically average sample.
Authority Warning

Regulators in several countries have added depressed mood, depression and suicidal ideation to finasteride labeling, and European regulators list suicidal thoughts as a side effect at a frequency that cannot be estimated from the available data.

What is post-finasteride syndrome and how strong is the evidence for it?

Here's the thing most articles skip: this is a term patients created, not a diagnosis that came out of clinical research. That doesn't make it fiction, and it doesn't make it proven either. It means you're reading reports, and reports can't tell you what caused what.

What's documented: Men report sexual, physical and mental symptoms continuing for months or years after they stop.
Genital numbness, lost libido, insomnia, anxiety and cognitive slowing dominate the accounts.
What's proposed: Lasting androgen receptor changes, epigenetic shifts, and durable neurosteroid suppression.
All of it rests on preliminary laboratory work, none of it confirmed in people.
What's unknown: How often it actually happens, with published estimates spanning very rare to a few percent.
Critical Warning

Post-finasteride syndrome is a patient-originated term for symptoms reported to persist after discontinuation, and no properly controlled prospective study has produced a reliable figure for how often it occurs.

How do side effects differ between the 1 mg hair loss dose and the 5 mg prostate dose?

You'd assume five times the dose means five times the exposure, and it doesn't. DHT suppression hits a ceiling early, so the extra four milligrams buy very little additional enzyme blocking. The reported side effect rates still look worse at 5 mg, and the reason is mostly who's taking it.

Measure 1 mg (hair loss) 5 mg (prostate)
Serum DHT suppression ~70% ~70 to 75%
Impotence reported under 2% near 8% (vs under 4% placebo)
Decreased libido reported ~1.8% near 6%
Typical age of men studied 20s to 40s 60s and 70s
Decision Point

The 5 mg dose adds almost no extra DHT suppression over the 1 mg dose, roughly 70 to 75 percent against roughly 70 percent, so its higher reported side effect rates track the age and prostate disease of the men studied far more than the milligrams.

How does finasteride affect fertility, semen, and pregnancy safety?

Two different worries get tangled together here, and they need separate answers. One is about your own sperm. The other is about a developing male fetus, and that one comes down to something as ordinary as whether a tablet in your bathroom is whole or broken in half.

You're actively trying to conceive: Pause the drug. Case series document real drops in sperm count in some men, with parameters generally recovering within a few months of stopping.
Your partner is or could become pregnant: Keep every tablet intact. The film coating exists to stop skin contact, and she should never handle a crushed or broken one.
You're worried about exposure through semen: Measured concentrations work out hundreds of times below the dose that moved DHT at all, and regulators haven't judged it a meaningful risk.
Compliance Note

Women who are or may become pregnant must not handle crushed or broken finasteride tablets, while intact film-coated tablets and the concentrations measured in semen present no established risk to a partner.

Who should avoid finasteride, and what warnings apply before starting it?

The list of people who genuinely can't take this is short. The list of things easy to skip in a five minute telehealth consult is longer, and the PSA problem is the one that can quietly cost a man years.

  • Absolute stops: Pregnancy, possible pregnancy, and known hypersensitivity. Everything else is judgment.
  • PSA distortion: Readings fall 40 to 50 percent within about a year, so double them.
  • Breast changes: Any new lump, skin dimpling or nipple discharge means investigate now.
  • Liver caution: Severe impairment warrants care, though no dose adjustment is formally defined.
Regulatory Reality

Finasteride lowers PSA by roughly 40 to 50 percent within about a year even at the 1 mg dose, so a screening result taken during treatment must be doubled and read as a trend rather than an absolute number.

Do finasteride side effects go away after stopping the drug?

For most men, yes, and faster than the internet suggests. The loudest accounts you'll find online are by definition the exceptions, but the exceptions are real too, and nobody has a defensible number for how many of them there are.

  1. Within two weeks: DHT climbs back toward baseline once you take the last tablet.
  2. Days to a few months: Most men reporting sexual or mood symptoms find they settle in this window.
  3. Within twelve months: Hair held by treatment is generally gone, arriving as an abrupt catch-up.
  4. Beyond that: A minority report symptoms outlasting any plausible washout, and attribution gets harder as normal age-related decline continues.
The Long View

DHT returns toward baseline within roughly two weeks of the last dose and most reported symptoms settle within days to a few months, but hair maintained by treatment is generally lost within twelve months of stopping.

Does topical finasteride lower the risk of side effects compared with the oral tablet?

The logic is sound: if the benefit happens at the follicle and the side effects happen everywhere else, a formulation that separates the two should keep one and shrink the other. The data shows partial separation, and the word that matters is partial.

Measure Topical 0.25% solution Oral 1 mg tablet
Serum DHT suppression ~35% ~56%
Hair count improvement comparable comparable
US regulatory status none approved, compounded approved product
Daily routine scalp application, must dry one tablet
The Deciding Factor

A 0.25 percent topical solution matched oral 1 mg on hair count while suppressing serum DHT about 35 percent against about 56 percent, which is less systemic exposure rather than none.

What options exist for treating hair loss without finasteride?

Start with what you're actually asking the alternative to do. Finasteride works by removing the hormonal driver, so anything replacing it either attacks that driver another way or helps the follicle by a completely different route. Which one you want depends on why you're leaving.

You want no hormonal mechanism at all: Platelet-rich plasma injections use your own concentrated platelets and growth factors delivered into the scalp on a schedule, with nothing acting on DHT.
You want the simplest proven substitute: Topical minoxidil is available without a prescription and extends the growth phase, with local irritation, facial hair from runoff, and an early shedding phase to expect.
You've lost density that won't come back: Transplantation is the only route that puts hair where none remains, though it redistributes rather than protects, so untreated native hair keeps receding.
You're tempted by dutasteride after a bad reaction: That's the wrong instinct, since it blocks both isoenzymes, suppresses DHT more deeply and clears far more slowly.
Pro Tip

Topical minoxidil, low dose oral minoxidil, platelet-rich plasma injections, laser devices and surgical transplantation all work without blocking DHT, while dutasteride suppresses it more deeply than finasteride and is a poor substitute for a man who reacted badly.

Daniel Zengel
Written by Daniel Zengel
Medical Writer
Daniel Zengel is the principal owner of H-SHOT and a medical writer covering platelet-rich plasma and hair restoration. He draws on more than a decade in pharmaceutical and medical device roles, with a focus on regenerative medicine and the device standards and provider training that make PRP results consistent from clinic to clinic.